This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
All NIHB Plan Members Ages 2 Years and Older
Managing their Type 1 and Type 2 Diabetes with Insulin
are Eligible for Dexcom G6 Coverage
Study Finds Poor Attainment of Glycemic Targets Across Canada Affected by Income and Location– Canadian Journal of Diabetes- September 11, 2023
Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies – Diabetes Technology & Therapeutics – August 2023
New Supplement Highlights the Latest CGM Evidence and Insights – Diabetes Technology and Therapeutics – June 2023
LOIS-P Looks at Hypoglycemia Incidence with Sensor-Augmented Pump in Pregnancy – Diabetes Technology and Therapeutics
LOIS-P Study Examines Insulin Use and Glycemic Control in Pregnancy with CGM – Diabetes Technology and Therapeutics – November, 2021
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021 – Canadian Journal of Diabetes – 2021
American Association of Clinical Endocrinology [AACE] Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus – AACE Endocrine Practice – June 2021
Diabetes Technology Standards of Medical Care in Diabetes 2021 – American Diabetes Association – Diabetes Care – 2021
Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy – Diabetes Technology & Therapeutics – March 2021
NICE Guideline Update: Diabetes in pregnancy: Management from preconception to the postnatal period – www.nice.org.uk – 2020